版本:
中国

BRIEF-Array Biopharma & Ono Pharmaceutical announce partnership for two Novel Oncology compounds

May 31 Array Biopharma Inc

* Array Biopharma & Ono Pharmaceutical Co Ltd announce license, development & commercialization partnership for 2 Novel Oncology compounds, Binimetinib and Encorafenib

* Array Biopharma says Array to receive $31.6 million up-front payment and up to $156.0 million in additional development and commercial milestones

* Ono will receive rights to develop and commercialize Binimetinib and Encorafenib in Japan and South Korea Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐